If this is your first visit, be sure to check out the FAQ in HCMA Announcements. You may have to register before you can post: click the register link above to proceed. To start viewing messages, select the forum that you want to visit from the selection below. Your Participation in this message board is strictly voluntary. Information and comments on the message board do not necessarily reflect the feelings, opinions, or positions of the Hypertrophic Cardiomyopathy Association. At no time should participants to this board substitute information within for individual medical advice. The Hypertrophic Cardiomyopathy Association shall not be liable for any information provided herein. All participants in this board should conduct themselves in a professional and respectful manner. Failure to do so will result in suspension or termination. The moderators of the message board working with the HCMA will be responsible for notifying participants if they have violated the rules of conduct for the board. Moderators or HCMA staff may edit any post to ensure it conforms with the rules of the board or may delete it. This community is welcoming to all those with HCM we ask that you remember each user comes to the board with information and a point of view that may differ from that which you hold, respect is critical, please post respectfully. Thank you


No announcement yet.

Replacement for coumadin not happenin'


About the Author


Boz Find out more about Boz
  • Filter
  • Time
  • Show
Clear All
new posts

  • Replacement for coumadin not happenin'

    Apparently, the new drug intended as a replacement for coumadin, has been shown to be unsafe and will not get the required FDA approval.

    I’ve had more than one Dr. tell me about the exciting new drug that is “just around the corner.” A blood thinner intended for patients like me; those with atrial fibrillation at risk for forming blood clots that can cause a stroke. Coumadin requires frequent blood tests to keep the patient at precise levels, Exanta would be available in a common dosage and not require frequent monitoring.

    Oh well, I guess I will cancel my pending stock order in AstraZeneca.
    • 1995: Brigham & Women’s Hospital - diagnosed with Atrial Fibrillation
    • 2004: Falkner Hospital – diagnosed with Congestive Heart Failure
    • 2004: Tufts NEMC– diagnosed with “End Stage” Hypertrophic Cardiomyopathy
    • 2005: Genetic Test – Laboratory for Molecular Medicine. HCM confirmed – missense mutation detected in TNNT2 gene
    • 2009: Brigham & Women’s - Third cardioversion begin Amiodarone for AFib
    • 2011: Brigham & Women’s - Medtronic ICD implant